Biotech Focus Forepont Capital Partners specializes in Medtech, biotech, and digital health startups across US and Europe. Target opportunities include portfolio companies or potential investments in early to growth-stage biotech and medtech firms that could benefit from their scientific, technological, financial, and operational support.

Strategic Partnerships The firm has strong, tight partnerships with researchers, hospitals, academia, and large pharmaceutical groups, which can be leveraged to source exclusive deal flow, co-investment opportunities, and pilot programs with potential strategic customers or collaborators.

Recent Investments Active activity in 2023–2024 includes leading or co-leading Series A/B rounds for Precision Neuroscience and Basecamp Vascular. Use cases include outreach to similar medtech and biotech series-stage opportunities seeking reputable VC backing and operational support.

Geographic Reach Headquartered in New York with European presence, offering cross-Atlantic collaboration. Sales opportunities exist in both US and European markets, including potential introductions to hospital networks, research institutions, and regulatory-enabled ventures.

Fundraising Footprint Revenue scale and investor credibility are indicated by a mid-market fund with notable exits and a focus on knowledge-intensive sectors. Approaches could target co-investments, strategic exits, or syndication opportunities with other large-cap PE players that align with their biotech and medtech thesis.